CNO Financial Group Reports Third Quarter 2026 Results
CNO Financial Group, Inc. (CNO) filed an SEC Form 8-K — Results of Operations and Financial Condition. News For Immediate Release CNO Financial Group Reports Third Quarter 2026 Results Carmel, Ind., October 29, 2026 - CNO Financial Group, Inc. (NYSE: CNO) today reported its third quarter 2026 financial results: • Raising 2026 operating earnings per share (EPS) guidance with the mi
Facts are quoted from the filing text and checked against it.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise provide fresh, material information that can affect the stock price immediately.
Market read
Strong earnings and raised guidance make CNO a near‑term buying candidate for investors seeking exposure to profitable insurers.
What to watch
The $44.9 million actuarial adjustment may be a one‑time boost; future quarters could normalize.
CNO Financial Group Reports Third Quarter 2026 Results
Third-quarter net operating income rose to $179.1 million from $127.2 million, operating EPS rose 47% to $1.90, net income increased to $161.1 million from $23.1 million, and the company raised 2026 operating EPS guidance with the midpoint up 9% from prior guidance.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Q3 2026 total revenuesGAAP | $1.09B | – | – |
| Nine months ended September 30, 2026 total revenuesGAAP | $3.40B | – | – |
| Q3 2026 insurance policy incomeGAAP | $688.2M | – | – |
| Q3 2026 general account net investment incomeGAAP | $441.5M | – | – |
| Q3 2026 policyholder and other special-purpose portfolios net investment incomeGAAP | $6.1M | – | – |
| Q3 2026 total investment lossesGAAP | −$64.7M | – | – |
| Q3 2026 fee revenue and other incomeGAAP | $14.9M | – | – |
| Q3 2026 insurance policy benefitsGAAP | $565.1M | – | – |
| Q3 2026 liability for future policy benefits remeasurement gainGAAP | −$52.5M | – | – |
| Q3 2026 change in fair value of market risk benefitsGAAP | −$28.8M | – | – |
| Q3 2026 interest expenseGAAP | $58.1M | – | – |
| Q3 2026 amortization of deferred acquisition costs and present value of future profitsGAAP | $76.8M | – | – |
| Q3 2026 goodwill and other asset impairmentGAAP | — | – | – |
| Q3 2026 other operating costs and expensesGAAP | $240.9M | – | – |
| Q3 2026 total benefits and expensesGAAP | $859.6M | – | – |
| Q3 2026 income before income taxesGAAP | $226.4M | – | – |
| Q3 2026 income tax expenseGAAP | $65.3M | – | – |
| Q3 2026 net incomeGAAP | $161.1M | – | – |
| Nine months ended September 30, 2026 net incomeGAAP | $324.7M | – | – |
| Q3 2026 diluted net income per common shareGAAP | $1.71 | – | – |
| Nine months ended September 30, 2026 diluted net income per common shareGAAP | $3.41 | – | – |
| Q3 2026 net operating incomenon-GAAP | $179.1M | – | 41% |
| Q3 2026 net operating income per diluted sharenon-GAAP | $1.90 | – | 47% |
| Q3 2026 net operating income excluding significant itemsnon-GAAP | $134.2M | – | – |
| Q3 2026 net operating income per diluted share excluding significant itemsnon-GAAP | $1.42 | – | – |
| Trailing four quarters return on equityGAAP | 16.4% | – | – |
| Trailing four quarters operating return on equitynon-GAAP | 15.4% | – | – |
| Trailing four quarters operating return on equity excluding significant itemsnon-GAAP | 14.1% | – | – |
| Book value per share at September 30, 2026GAAP | $25.34 | – | – |
| Book value per diluted share excluding accumulated other comprehensive loss at September 30, 2026non-GAAP | $41.29 | – | up 8% |
2026 outlook
- NoteRaising 2026 operating earnings per share (EPS) guidance with the midpoint up 9% from our prior guidance.
Capital returns
- During 3Q26, we repurchased $60.0 million of common stock under our securities repurchase program.
- We repurchased 1.1 million common shares at an average cost of $54.52 per share.
- As of September 30, 2026, we had authority to repurchase up to an additional $240.4 million of our common stock.
- During 3Q26, dividends paid on common stock totaled $16.5 million.
- There were no company dividends paid to the holding company during 3Q26.
What drove it
- Income from insurance products was $172.0 million, compared to $149.5 million in 3Q25.
- Investment income not allocated to product lines was $68.1 million, compared to $39.5 million in 3Q25.
- Significant items had a $44.9 million net favorable impact on both net income and net operating income in 3Q26, compared to $32.2 million in 3Q25.
- Total new annualized premiums were up for a 17th consecutive quarter, and the company reported continued growth in asset accumulation products.
- Consumer and Worksite delivered their 15th and 17th consecutive quarters of producing agent count growth, respectively.
- On October 1, 2026, CNO closed a third reinsurance transaction with its wholly owned Bermuda affiliate, reinsuring approximately $270 million of inforce graded benefit life statutory reserves from Colonial Penn.
Concerns
- Q3 2026 total revenues were $1,086.0 million, compared to $1,188.7 million in 3Q25.
- Q3 2026 total investment losses were $(64.7) million, compared to $(3.0) million in 3Q25.
- Net realized investment losses were $48.3 million in 3Q26, including the unfavorable change in the allowance for credit losses of $5.4 million.
- CNO recognized a $22.1 million valuation allowance on deferred tax assets associated with capital loss carryforwards.
- Expenses related to the TechMod initiative were $10.1 million in 3Q26, compared with $7.2 million in 3Q25.
- Unrestricted cash and investments held by the holding company declined to $230.7 million at September 30, 2026 from $351.4 million at December 31, 2025.
What to watch
- The numerical range for raised 2026 operating EPS guidance was not provided in the release.
- The execution and financial effects of the October 1, 2026 internal reinsurance transaction covering approximately $270 million of inforce graded benefit life statutory reserves.
- Future realized investment results, allowance for credit losses, changes in market value of investments, and fair-value changes in embedded derivative liabilities and market risk benefits.
- The cost trajectory and completion of the TechMod technology modernization initiative.
- Sustainability of new annualized premium growth, asset accumulation product growth, and producing agent count growth.
Balance sheet and cash flow
- Unrestricted cash and investments held by our holding company were $230.7 million at September 30, 2026 compared to $351.4 million at December 31, 2025.
- Shareholders’ equity was $2,323.7 million at September 30, 2026 compared to $2,611.0 million at September 30, 2025.
- The debt-to-capital ratio was 36.5% and 33.6% at September 30, 2026 and December 31, 2025, respectively.
- Our debt-to-total capital ratio, excluding accumulated other comprehensive income (loss), was 25.7% and 26.2% at September 30, 2026 and December 31, 2025, respectively.
- The consolidated statutory risk-based capital ratio of U.S. based insurance subsidiaries was estimated at 374% at September 30, 2026, reflecting estimated 3Q26 statutory operating gain of $21.9 million.
- Operating cash flow and free cash flow were not reported.
Analysis
CNO reported a substantially stronger third quarter on both GAAP and operating measures. Net income was $161.1 million, or $1.71 per diluted share, compared with $23.1 million, or $0.24 per diluted share, in 3Q25. Net operating income was $179.1 million, or $1.90 per diluted share, compared with $127.2 million, or $1.29 per diluted share. The company stated that operating EPS grew 47% in the quarter and 43% year-to-date.
Underlying operating results reflected higher income from insurance products and higher investment income not allocated to product lines. Income from insurance products was $172.0 million versus $149.5 million in 3Q25, while investment income not allocated to product lines was $68.1 million versus $39.5 million. The quarter included $44.9 million of significant items that favorably affected both net income and net operating income. Excluding significant items, net operating income was $134.2 million and net operating income per diluted share was $1.42.
GAAP revenue declined to $1,086.0 million from $1,188.7 million. General account net investment income increased to $441.5 million from $382.9 million, but policyholder and other special-purpose portfolios net investment income fell to $6.1 million from $116.8 million, and fee revenue and other income declined to $14.9 million from $33.6 million. Total investment losses were $(64.7) million compared with $(3.0) million, including net realized investment losses of $48.3 million. CNO also recorded a $22.1 million valuation allowance on deferred tax assets associated with capital loss carryforwards.
Capital returns included $60.0 million of share repurchases and $16.5 million of common dividends during 3Q26. The company had $240.4 million of remaining repurchase authority at September 30, 2026. Unrestricted holding-company cash and investments were $230.7 million, compared with $351.4 million at December 31, 2025. The debt-to-capital ratio was 36.5%, while debt-to-total capital excluding accumulated other comprehensive income loss was 25.7%.
CNO raised 2026 operating EPS guidance, stating that the midpoint increased 9% from prior guidance, although it did not disclose the revised range. The company highlighted a 17th consecutive quarter of total new annualized premium growth, continued asset accumulation product growth, and ongoing producer-count growth in Consumer and Worksite. The October 1 internal reinsurance transaction reinsured approximately $270 million of inforce graded benefit life statutory reserves from Colonial Penn.
Management, verbatim
CNO delivered an excellent quarter, with operating earnings per share up 47% and our 17 th consecutive quarter of sales growth.
Gary C. Bhojwani, chief executive officer
Our momentum reflects disciplined execution across the business and continued improvement in profitability.
Gary C. Bhojwani, chief executive officer
Based on these results, we are raising our full-year operating earnings per share guidance.
Gary C. Bhojwani, chief executive officer
Not in the filing
stated, not guessed- Numerical 2026 operating EPS guidance range and midpoint
- Prior 2026 operating EPS guidance range and midpoint
- Operating cash flow
- Free cash flow
- Gross margin
- Segment revenue disclosure
- Quarter-over-quarter total revenue comparison
- Quarter-over-quarter diluted GAAP EPS comparison
- Quantitative total new annualized premiums
- Quantitative asset accumulation product growth
- Quantitative producing agent count growth
- Total debt amount
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
CNO Financial Group filed a Form 8‑K reporting its Q3 2026 results, including a 9% raise in EPS guidance and a 47% quarterly EPS increase.
Ticker impact
CNO Financial Group raised its 2026 operating EPS guidance by 9% and reported a 47% quarterly EPS increase.
likely upside as investors price in the raised guidance
The 9% guidance increase and 47% EPS growth are fresh, material data that can drive the stock higher in the near term.
Market effects
Positive signal for the life‑insurance sector as earnings beat and guidance raise may lift peers.
U.S. market participants may view the results as a boost to financial services stocks.
Limited to investors tracking U.S. insurers; no broader macro effect.
Counterpoint
If the market has already priced in the strong quarter, the stock could face a short‑term pullback.
Key entities
- companyCNO Financial Group
U.S. life‑insurance and annuity provider (NYSE:CNO).
